Track 10: Challenges in Rare Diseases Treatment

There are around 7,000 rare diseases, which from a regulatory outlook are defined as those diseases where there are less than 200,000 patients in the US or that affect no more than five in 10,000 of the general population in the EU. Orphan drugs are medicinal products envisioned for diagnosis, prevention, and treatment of life-threatening rare diseases. They are "orphans" because the pharmaceutical industry has little interest under normal market conditions in developing and marketing drugs intended for only a small number of patients suffering from very rare conditions.

 

    Related Conference of Track 10: Challenges in Rare Diseases Treatment

    October 21-22, 2019

    15th World Congress on Infection Prevention and Control

    ZURICH | SWITZERLAND Venue: Movenpick Hotel Zürich Airport
    November 25-26, 2019

    2nd World Congress on Rare Diseases

    Dubai, UAE
    January 27-28, 2020

    3rd Global Experts Meeting on Infectious Diseases

    | Bangkok, Thailand
    February 24-25, 2020

    7th International Congress on Infectious Diseases

    Berlin, Germany
    March 11-12, 2020

    8th International Conference on HIV AIDS STD & STIs

    Barcelona, Spain
    March 27-28, 2020

    5th Annual Congress on Infectious Diseases

    Barcelona, Spain
    May 18-19, 2020

    7th Global Congress on Rare Diseases & Orphan Drug

    Istanbul, Turkey
    July 22-23, 2020

    10th World Congress on Rare Diseases and Orphan Drugs

    Barcelona, Spain
    October 05-06, 2020

    12th Euro-Global Conference on Infectious Diseases

    Vienna, Austria
    October 12-13, 2020

    7th International Conference on Infectious Diseases & Antibiotics

    Prague, Czech republic
    September 28-29, 2020

    13th Global Infections Conference

    | Singapore
    December 06-07, 2021

    3rd World Congress on Rare Diseases

    Dubai, UAE

    Track 10: Challenges in Rare Diseases Treatment Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in